Přihlásit se Zaregistrujte se zdarma

EBIT margin společnosti Albireo Pharma Inc

Jaká je hodnota metriky EBIT margin společnosti Albireo Pharma Inc?

Hodnota metriky EBIT margin společnosti Albireo Pharma Inc je -215.23%

Jaká je definice metriky EBIT margin?



EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.

ttm (trailing twelve months)

EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.

EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.

EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.

EBIT margin společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Albireo Pharma Inc

Čemu se věnuje společnost Albireo Pharma Inc?

Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Firmy s metrikou ebit margin podobnou společnosti Albireo Pharma Inc



  • Hodnota metriky EBIT margin společnosti scPharmaceuticals Inc je -217.30%
  • Hodnota metriky EBIT margin společnosti General Assembly je -216.90%
  • Hodnota metriky EBIT margin společnosti ManifestSeven je -216.20%
  • Hodnota metriky EBIT margin společnosti Pentamedia Graphics je -216.09%
  • Hodnota metriky EBIT margin společnosti Cann je -215.76%
  • Hodnota metriky EBIT margin společnosti SSPDL je -215.40%
  • Hodnota metriky EBIT margin společnosti Albireo Pharma Inc je -215.23%
  • Hodnota metriky EBIT margin společnosti TDH Inc je -214.49%
  • Hodnota metriky EBIT margin společnosti Applied Dna Sciences Inc je -214.48%
  • Hodnota metriky EBIT margin společnosti Duos Technologies je -213.92%
  • Hodnota metriky EBIT margin společnosti CCUR je -213.74%
  • Hodnota metriky EBIT margin společnosti Desktop Metal je -213.66%
  • Hodnota metriky EBIT margin společnosti Oncimmune plc je -212.90%